A review of active ingredients from Cannabis Sativa L. and their medicinal potential

Li CHANG,Jianjun LI,Siqi HUANG,Huijuan TANG,Anguo CHEN,Cuiping ZHANG,Li'ning ZHAO,Defang LI
DOI: https://doi.org/10.13488/j.smhx.20180215
2018-01-01
Abstract:Cannabis sativa L. is one of the oldest plants used for medicine because of its numerous natural constituents. From the 1960s to the present, a total of 565 constituents have been reported from Cannabis sativa L., which could be classified into two types: phytocannabinoids and non-cannabinoids. These active constituents are responsible for analgesic, anti-tumor, anti-nausea and vomiting, treatment and brain disease, anti-inflammatory, anti-bacterial, etc. However, the pharmacological mechanism was gradually revealed in the past 50 years, and still need further study. In this paper, we present a general overview of chemical constituents in Cannabis sativa L., biosynthetic pathways of cannabinoids and key enzymes involved, techniques of determining cannabinoids, and the main potential (or established) therapeutic uses of some cannabis-related drugs, to provide reference for pharmacology and therapeutic potential of Cannabis sativa L..
What problem does this paper attempt to address?